Literature DB >> 11723451

Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation.

J P Tsikouris1, J Kluger, J Song, C M White.   

Abstract

BACKGROUND: Increased P-wave dispersion (P-disp) and maximum P-wave duration (P-max) predict the development of atrial fibrillation (AF) in the general population. The present study evaluates the time-dependent relationship of P-disp and P-max after open heart surgery. METHODS AND
RESULTS: P-disp and P-max were measured in the perioperative period of open heart surgery (one day before surgery through postoperative day 4). Compared with the baseline, P-max decreased immediately after open heart surgery (112.63 +/- 7.4 ms vs 106.9 +/- 8.2 ms, P =.005). An increase in P-disp was observed between postoperative days 1 and 2 (37.5 +/- 6.8 ms vs 43.1 +/- 4.5 ms, P <.05), and postoperative days 1 and 3 (37.5 +/- 6.8 ms vs 44.1 +/- 6.6 ms, P <.05). There was also an increase in the P-max between postoperative day 1 and 3 (103 +/- 8.3 ms vs 110 +/- 7.7 ms, P <.05).
CONCLUSIONS: Nonuniform atrial conduction (P-disp) is greatest on days 2 and 3 after open heart surgery, and the longest atrial conduction time (P-max) is greatest on day 3 after open heart surgery, findings that coincide with the time of greatest risk for AF. (Heart Lung((R)) 2001;30:466-71.)

Entities:  

Mesh:

Year:  2001        PMID: 11723451     DOI: 10.1067/mhl.2001.118363

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  19 in total

1.  New automated detection method of OSA based on artificial neural networks using P-wave shape and time changes.

Authors:  Khaldon Lweesy; Luay Fraiwan; Natheer Khasawneh; Hartmut Dickhaus
Journal:  J Med Syst       Date:  2009-12-12       Impact factor: 4.460

2.  Risk Factors for Post-Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation and the Role of Aspirin and Beta Blockers in its Prevention.

Authors:  Muhammad F Khan; Aravind Herle; Mohammad Reza Movahed
Journal:  J Atr Fibrillation       Date:  2013-02-12

3.  The effects of zoledronic acid on ECG: a prospective study on patients with bone metastatic cancer.

Authors:  Derya Demirtas; Cemil Bilir; Abdullah Orhan Demirtas; Huseyin Engin
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

4.  The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation.

Authors:  Zerrin Yiğit; Hülya Akdur; Murat Ersanli; Bariş Okçün; Ozen Güven
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-10       Impact factor: 1.468

5.  Maximum p wave duration and p wave dispersion in adult patients with secundum atrial septal defect: the impact of surgical repair.

Authors:  Umit Guray; Yesim Guray; Burcu Mecit; M Birhan Yilmaz; Hatice Sasmaz; Sule Korkmaz
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

6.  Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults.

Authors:  Mehmet G Kaya; Ali Baykan; Ali Dogan; Tugrul Inanc; Ozgur Gunebakmaz; Orhan Dogdu; Kazim Uzum; Namik K Eryol; Nazmi Narin
Journal:  Pediatr Cardiol       Date:  2010-01-19       Impact factor: 1.655

7.  Effect of birth asphyxia on p wave dispersion.

Authors:  Hamid Amoozgar; Monirosadat Barekati; Nahal Farhani; Narjes Pishva
Journal:  Indian J Pediatr       Date:  2013-05-03       Impact factor: 1.967

8.  Predictive value of P-wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation.

Authors:  Mohammad Hashemi Jazi; Afshin Amirpour; Reihaneh Zavvar; Mohaddeseh Behjati; Mojgan Gharipour
Journal:  ARYA Atheroscler       Date:  2012

9.  Postoperative atrial fibrillation.

Authors:  C Chelazzi; G Villa; A R De Gaudio
Journal:  ISRN Cardiol       Date:  2011-05-22

10.  P-wave duration and dispersion in patients with peripheral edema and its amelioration.

Authors:  John E Madias
Journal:  Indian Pacing Electrophysiol J       Date:  2007-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.